Published in J Virol on January 01, 2000
Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31. J Virol (2004) 1.35
Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. J Virol (2007) 1.34
Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling. Oncogene (2012) 1.27
Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins. Science (2013) 1.22
Papillomavirus E6 oncoproteins. Virology (2013) 1.21
Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function. PLoS One (2013) 0.90
Transformation by bovine papillomavirus type 1 E6 requires paxillin. J Virol (2008) 0.89
Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6. Protein Expr Purif (2011) 0.86
Bovine papillomavirus E5 and E7 oncoproteins in naturally occurring tumors: are two better than one? Infect Agent Cancer (2013) 0.84
Loss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expression. Am J Pathol (2002) 0.84
Mutagenic Potential ofBos taurus Papillomavirus Type 1 E6 Recombinant Protein: First Description. Biomed Res Int (2015) 0.75
Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A (1993) 22.33
Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate. Anal Biochem (1979) 22.03
A rapid method for localized mutagenesis of yeast genes. Yeast (1992) 7.79
Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol (1993) 4.04
Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol (1993) 2.91
A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci U S A (1995) 2.70
Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science (1995) 2.20
Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res (1992) 2.07
The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc Natl Acad Sci U S A (1997) 2.00
The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation. Mol Cell Biol (1999) 1.84
Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene (1998) 1.78
Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene (1998) 1.69
Paxillin LD motifs may define a new family of protein recognition domains. Nat Struct Biol (1998) 1.52
Identification of an alpha helical motif sufficient for association with papillomavirus E6. J Biol Chem (1998) 1.45
E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J Biol Chem (1998) 1.45
The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase. J Biol Chem (1997) 1.27
Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein. EMBO J (1990) 1.27
Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein. Biochem Biophys Res Commun (1998) 1.15
Negative regulation of the bovine papillomavirus E5, E6, and E7 oncogenes by the viral E1 and E2 genes. J Virol (1995) 1.07
Transformation by bovine papillomavirus type 1 E6 is independent of transcriptional activation by E6. J Virol (1997) 0.90
Staging of Alzheimer-related cortical destruction. Eur Neurol (1993) 3.58
Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain Technol (1988) 2.55
Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci (1999) 2.30
Alzheimer's disease: amyloid plaques in the cerebellum. J Neurol Sci (1989) 2.08
The presubicular region in Alzheimer's disease: topography of amyloid deposits and neurofibrillary changes. Brain Res (1989) 1.93
Alzheimer's disease: mismatch between amyloid plaques and neuritic plaques. Neurosci Lett (1989) 1.91
Evolution of Alzheimer's disease related cortical lesions. J Neural Transm Suppl (1998) 1.57
Functional anatomy of human hippocampal formation and related structures. J Child Neurol (1996) 1.53
Changes of the ratio between myelin thickness and axon diameter in the human developing sural nerve. Acta Neuropathol (1978) 1.45
Mental retardation syndrome with renal concentration deficiency and intracerebral calcification. Eur J Pediatr (1990) 1.40
Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling. Oncogene (2012) 1.27
Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience (1995) 1.27
Characterization of the cis elements involved in basal and E2-transactivated expression of the bovine papillomavirus P2443 promoter. J Virol (1991) 1.23
Pattern of brain destruction in Parkinson's and Alzheimer's diseases. J Neural Transm (Vienna) (1996) 1.20
Acute trimethyltin limbic-cerebellar syndrome. Neurology (1987) 1.19
Monoclonal antibodies SMI 311 and SMI 312 as tools to investigate the maturation of nerve cells and axonal patterns in human fetal brain. Cell Tissue Res (1998) 1.18
Contribution of diffusion tensor imaging to delineation of gliomas and glioblastomas. J Magn Reson Imaging (2004) 1.13
Repression of bovine papillomavirus type 1 transcription by the E1 replication protein. J Virol (1993) 1.13
Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience (1995) 1.12
Competitive binding to a charged leucine motif represses transformation by a papillomavirus E6 oncoprotein. Virology (2000) 1.09
Esophageal motor function in patients with muscular dystrophy. Gastroenterology (1986) 1.07
Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions. Acta Neuropathol (1999) 1.06
Unbiased estimation of neuronal numbers in the human nucleus coeruleus during aging. Neurobiol Aging (1997) 1.02
Amygdala pathology in Parkinson's disease. Acta Neuropathol (1994) 0.99
Transcatheter embolization of the kidney with butyl-2-cyanoacrylate: experimental and clinical results. Cardiovasc Radiol (1978) 0.98
Nephrogenic diabetes insipidus and intracerebral calcification. Arch Dis Child (1990) 0.98
Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus. Neurobiol Aging (1997) 0.95
Allocortical neurofibrillary changes in progressive supranuclear palsy. Acta Neuropathol (1992) 0.95
Dissection of the internal carotid artery after chiropractic manipulation of the neck. Neurology (1995) 0.92
Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease. Neurosci Lett (1996) 0.91
Distribution of SNAP-25 in transient neuronal circuitries of the developing human forebrain. Neuroreport (2000) 0.90
Cooperative transformation and coexpression of bovine papillomavirus type 1 E5 and E7 proteins. J Virol (2001) 0.90
Pathological changes in the parahippocampal region in select non-Alzheimer's dementias. Ann N Y Acad Sci (2000) 0.90
Traumatic lesion of the extracranial vertebral artery--a note-worthy potentially lethal injury. Int J Legal Med (1994) 0.89
Transient structures of the human fetal brain: subplate, thalamic reticular complex, ganglionic eminence. Histol Histopathol (2000) 0.89
Senile amyloidosis: principles of localization in a heterogeneous form of amyloidosis. Virchows Arch B Cell Pathol Incl Mol Pathol (1983) 0.88
Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico-pathological insights. Neuropathol Appl Neurobiol (2012) 0.88
Changes of the ratio between myelin thickness and axon diameter in human developing sural, femoral, ulnar, facial, and trochlear nerves. Acta Neuropathol (1988) 0.88
Amyloidoma of the gasserian ganglion as a cause of symptomatic neuralgia of the trigeminal nerve: report of three cases. J Neurol (1993) 0.87
Dyke Postmortem CT and Award. autopsy in perinatal intracranial hemorrhage. AJNR Am J Neuroradiol (1983) 0.87
Polyneuropathy due to acute arsenic intoxication: biopsy studies. J Neuropathol Exp Neurol (1990) 0.87
Leptomeningeal carcinomatosis and cranial nerve palsy as presenting symptoms of a clinically inapparent gallbladder carcinoma. Pathol Res Pract (1999) 0.85
Cerebral haemorrhage in long-term survivors of childhood acute lymphoblastic leukaemia. Eur J Pediatr (1997) 0.84
Tissue characterization of benign brain tumors: use of NMR-tissue parameters. Magn Reson Imaging (1988) 0.84
Evolution of brain abscess in cats formation of capsule and resolution of brain edema. Neurosurg Rev (1980) 0.84
Giant aneurysm of the vertebral artery causing compression of the lower medulla oblongata. J Neurol (1977) 0.84
Transient features of the thalamic reticular nucleus in the human foetal brain. Eur J Neurosci (1998) 0.83
Transrenal ureteral occlusion using a detachable balloon. Urol Radiol (1984) 0.82
Apolipoprotein E polymorphism is associated with both senile plaque load and Alzheimer-type neurofibrillary tangle formation. Ann N Y Acad Sci (1996) 0.82
Spinocerebellar ataxias types 2 and 3: degeneration of the pre-cerebellar nuclei isolates the three phylogenetically defined regions of the cerebellum. J Neural Transm (Vienna) (2005) 0.81
New aspects of pathology in Parkinson's disease with concomitant incipient Alzheimer's disease. J Neural Transm Suppl (1996) 0.81
Image analysis of proliferating cells in tumors of the human nervous system: an immunohistological study with the monoclonal antibody Ki-67. Neurosurgery (1994) 0.80
[Evaluating the risk of sciatic nerve damage in the rabbit by administration of low and intermediate energy extracorporeal shock waves]. Z Orthop Ihre Grenzgeb (1999) 0.80
Colocalization of different types of amyloid in the walls of cerebral blood vessels of patients suffering from cerebral amyloid angiopathy and spontaneous intracranial hemorrhage: a report of 5 cases. Clin Neuropathol (2004) 0.80
Transient architectonic features in the basolateral amygdala of the human fetal brain. Acta Anat (Basel) (1998) 0.80
Quantitative investigations on the human entorhinal area: left-right asymmetry and age-related changes. Anat Embryol (Berl) (1994) 0.80
Possible involvement of the retinoblastoma gene in undifferentiated sinonasal carcinoma. Cancer (1990) 0.80
Rare association of herpes simplex virus IgM-specific antibodies and Guillain-Barré syndrome successfully treated with plasma exchange and immunosuppression. Klin Wochenschr (1985) 0.79
[Clinical, neurophysiologic and biopsy findings in neurotoxic amiodarone syndrome]. Med Klin (Munich) (1994) 0.79
Reduced basal and stimulated (isoprenaline, Gpp(NH)p, forskolin) adenylate cyclase activity in Alzheimer's disease correlated with histopathological changes. Brain Res (1991) 0.78
[Fatal outcome during physiotherapy (Vojta's method) in a 3-month old infant. Case report and comments on manual therapy in children]. Klin Padiatr (2001) 0.78
Adenylyl cyclase activity in Alzheimer's disease brain: stimulatory and inhibitory signal transduction pathways are differently affected. Brain Res (1994) 0.78
Results of 200 intracranial stereotactic biopsies. Neurosurg Rev (1994) 0.78
High proportion of dementia with Lewy bodies in the postmortems of a mental hospital in Germany. Int J Geriatr Psychiatry (1997) 0.77
A new type of leukoencephalopathy with metaphyseal chondrodysplasia maps to Xq25-q27. Neurology (2006) 0.77
[Clinical aspects of "argyrophilic grain disease"]. Nervenarzt (2000) 0.77
Development-related expression of AKAP79 in the striatal compartments of the human brain. Cells Tissues Organs (2001) 0.77
Organisation and maturation of the human thalamus as revealed by CD15. J Comp Neurol (2001) 0.77
[Trans-catheter embolisation of the spleen with butyl-2-cyanoacrylate. Experimental results and clinical application (author's transl)]. Rofo (1980) 0.77
Amyloid-related neuropathies. Zentralbl Allg Pathol (1990) 0.77
The lipofuscin content of nerve cells of the inferior olivary nucleus in Alzheimer's disease. Dementia (1994) 0.77
[MR tomography in glioblastomas and cerebral metastases]. Radiologe (1987) 0.77
Late-onset globoid cell leukodystrophy: unusual ultrastructural pathology and subtotal beta-galactocerebrosidase deficiency. J Child Neurol (1990) 0.76
Effect of fetal hydrocephalus on the distribution patterns of calcium-binding proteins in the human occipital cortex. Pediatr Neurosurg (2001) 0.76
Distribution patterns of vimentin-immunoreactive structures in the human prosencephalon during the second half of gestation. J Anat (1999) 0.76
Beta-adrenoceptor density and subtype distribution in cerebellum and hippocampus from patients with Alzheimer's disease. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.76
Distribution of GAP-43-immunoreactive structures in the human fetal amygdala. Eur J Histochem (1999) 0.76
Extended pathoanatomical studies point to a consistent affection of the thalamus in spinocerebellar ataxia type 2. Neuropathol Appl Neurobiol (2005) 0.76
Expression of MAP1a and MAP1b in the ganglionic eminence and the internal capsule of the human fetal brain. Neurosci Res (2000) 0.76
Immunohistochemistry of amyloid-related neuropathies. Clin Neuropathol (1992) 0.75
Hypokalemic rhabdomyolysis associated with Bartter's syndrome. Klin Wochenschr (1983) 0.75
[Cranial mucormycosis with thrombosis of the sinus cavernosus (author's transl)]. HNO (1979) 0.75
Reno-cerebral oxalosis induced by xylitol. Neuroradiology (1984) 0.75
Psychic stress as a trigger of the spontaneous development and rupture of an aneurysm? A case report. Interv Neuroradiol (2001) 0.75
[Traumatic rupture of the esophagus]. Zentralbl Chir (1983) 0.75
[Electron microscopy studies on hypertensive microangiopathy]. Med Welt (1975) 0.75
[Median nerve--compression syndrome caused by atypical palm muscle]. Handchir Mikrochir Plast Chir (1985) 0.75
[MR tomography of benign brain tumors]. Rofo (1987) 0.75
Alterations in the organization of the isocortical layer I in trisomy 22. Neurosci Res (1999) 0.75
[Can oxaloses be iatrogenically induced?]. Beitr Gerichtl Med (1986) 0.75
The nature of host tissue destruction in tumor invasion. An experimental investigation on carcinoma and sarcoma xenotransplants. Virchows Arch B Cell Pathol Incl Mol Pathol (1987) 0.75
[Local myocardial necrosis and cardiac tamponade due to a central venous catheter (author's transl)]. Anaesthesist (1979) 0.75
Neurodegenerative diseases. Neuroimaging Clin N Am (2001) 0.75
[Bilateral progressive hearing loss as the first manifestation of metastatic carcinoma of the head of the pancreas. Case report]. Laryngorhinootologie (2001) 0.75
[Experimental brain abscess evolution : brain edema and neuropathologic correlation (author's transl)]. Neurochirurgie (1980) 0.75
Transient expression of synaptogyrin in the ganglionic eminence of the human fetal brain. Ann Anat (2000) 0.75
[An unusual case of sarcoidosis with multiple organ involvement and fatal course]. Prax Klin Pneumol (1988) 0.75
Flow-cytometric DNA analysis of intracranial tumors in children. Pathol Res Pract (2004) 0.75